CIRM Funded Clinical Trials

Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease

Disease Area:

Parkinson's Disease

Investigator:

Dr. Edward Wirth III

Institution:

Aspen Neuroscience

CIRM Grant:

CLIN2-15547 (Active)

Award Value:

$8,000,000.00

Trial Sponsor:

Aspen Neuroscience, Inc.

Trial Stage:

Phase 1

Trial Status:

Launching

Targeted Enrollment:

N/A

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.